Large-scale transcriptomic analysis of coding and non-coding pathological biomarkers, associated with the tumor immune microenvironment of thyroid cancer and potential target therapy exploration

Papillary thyroid carcinoma (PTC) is the most prevalent endocrine malignancy with a steadily increasing global incidence in recent decades. The pathogenesis of PTC is poorly understood, and the present diagnostic protocols are deficient. Thus, identifying novel prognostic biomarkers to improve our u...

Full description

Bibliographic Details
Main Authors: Ming-Lang Shih, Bashir Lawal, Sheng-Yao Cheng, Janet O. Olugbodi, Ahmad O Babalghith, Ching-Liang Ho, Simona Cavalu, Gaber El-Saber Batiha, Sarah Albogami, Saqer S. Alotaibi, Jih-Chin Lee, Alexander T. H. Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2022.923503/full
_version_ 1811221449520709632
author Ming-Lang Shih
Bashir Lawal
Bashir Lawal
Sheng-Yao Cheng
Janet O. Olugbodi
Ahmad O Babalghith
Ching-Liang Ho
Simona Cavalu
Gaber El-Saber Batiha
Sarah Albogami
Saqer S. Alotaibi
Jih-Chin Lee
Alexander T. H. Wu
Alexander T. H. Wu
Alexander T. H. Wu
Alexander T. H. Wu
author_facet Ming-Lang Shih
Bashir Lawal
Bashir Lawal
Sheng-Yao Cheng
Janet O. Olugbodi
Ahmad O Babalghith
Ching-Liang Ho
Simona Cavalu
Gaber El-Saber Batiha
Sarah Albogami
Saqer S. Alotaibi
Jih-Chin Lee
Alexander T. H. Wu
Alexander T. H. Wu
Alexander T. H. Wu
Alexander T. H. Wu
author_sort Ming-Lang Shih
collection DOAJ
description Papillary thyroid carcinoma (PTC) is the most prevalent endocrine malignancy with a steadily increasing global incidence in recent decades. The pathogenesis of PTC is poorly understood, and the present diagnostic protocols are deficient. Thus, identifying novel prognostic biomarkers to improve our understanding of the mechanisms of pathogenesis, diagnosis, and designing therapeutic strategies for PTC is crucial. In this study, we integrated 27 PTC transcriptomic datasets and identified overlapping differentially expressed genes (DEGs) and differentially expressed microRNAs, collectively known as thyroid tumor-enriched proteins (TTEPs), and TTEmiRs, respectively. Our integrated bioinformatics analysis revealed that TTEPs were associated with tumor stages, poor surgical outcomes, distant metastasis, and worse prognoses in PTC cohorts. In addition, TTEPs were found to be associated with tumor immune infiltrating cells and immunosuppressive phenotypes of PTC. Enrichment analysis suggested the association of TTEPs with epithelial-to-mesenchymal transition (EMT), cell-matrix remodeling, and transcriptional dysregulation, while the TTEmiRs (miR-146b-5p and miR-21-5p) were associated with the modulation of the immune response, EMT, migration, cellular proliferation, and stemness. Molecular docking simulations were performed to evaluate binding affinities between TTEPs and antrocinnamomin, antcin, and antrocin, the bioactive compounds from one of the most reputable Taiwan indigenous medicinal plants (Antrodia camphorata). Our results revealed that antcin exhibited higher binding efficacies toward FN1, ETV5, and NRCAM, whereas antrocin demonstrated the least. Among the targets, fibronectin (FN1) demonstrated high ligandability potential for the compounds whereas NRCAM demonstrated the least. Collectively, our results hinted at the potential of antcin for targeting TTEPs. In conclusion, this comprehensive bioinformatics analysis strongly suggested that TTEPs and TTEmiRs could be used as potential diagnostic biomarker signatures and be exploited as potential targets for therapeutics development.
first_indexed 2024-04-12T07:59:30Z
format Article
id doaj.art-132447e514394794a600acae034c298a
institution Directory Open Access Journal
issn 2296-634X
language English
last_indexed 2024-04-12T07:59:30Z
publishDate 2022-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj.art-132447e514394794a600acae034c298a2022-12-22T03:41:22ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2022-08-011010.3389/fcell.2022.923503923503Large-scale transcriptomic analysis of coding and non-coding pathological biomarkers, associated with the tumor immune microenvironment of thyroid cancer and potential target therapy explorationMing-Lang Shih0Bashir Lawal1Bashir Lawal2Sheng-Yao Cheng3Janet O. Olugbodi4Ahmad O Babalghith5Ching-Liang Ho6Simona Cavalu7Gaber El-Saber Batiha8Sarah Albogami9Saqer S. Alotaibi10Jih-Chin Lee11Alexander T. H. Wu12Alexander T. H. Wu13Alexander T. H. Wu14Alexander T. H. Wu15Division of General Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, TaiwanPhD Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei, TaiwanGraduate Institute for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, TaiwanDepartment of Otolaryngology-Head and Neck Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, TaiwanDepartment of Biochemistry, Bingham University, Karu, NigeriaMedical Genetics Department, Faculty of Medicine, Umm al-Qura Univeristy, Mecca, Saudi ArabiaDivision of Hematology and Oncology Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, TaiwanFaculty of Medicine and Pharmacy, University of Oradea, Oradea, RomaniaDepartment of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour, Egypt0Department of Biotechnology, College of Science, Taif University, Taif, Saudi Arabia0Department of Biotechnology, College of Science, Taif University, Taif, Saudi ArabiaDepartment of Otolaryngology-Head and Neck Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan1The PhD Program of Translational Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan2Clinical Research Center, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan3TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan4Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, TaiwanPapillary thyroid carcinoma (PTC) is the most prevalent endocrine malignancy with a steadily increasing global incidence in recent decades. The pathogenesis of PTC is poorly understood, and the present diagnostic protocols are deficient. Thus, identifying novel prognostic biomarkers to improve our understanding of the mechanisms of pathogenesis, diagnosis, and designing therapeutic strategies for PTC is crucial. In this study, we integrated 27 PTC transcriptomic datasets and identified overlapping differentially expressed genes (DEGs) and differentially expressed microRNAs, collectively known as thyroid tumor-enriched proteins (TTEPs), and TTEmiRs, respectively. Our integrated bioinformatics analysis revealed that TTEPs were associated with tumor stages, poor surgical outcomes, distant metastasis, and worse prognoses in PTC cohorts. In addition, TTEPs were found to be associated with tumor immune infiltrating cells and immunosuppressive phenotypes of PTC. Enrichment analysis suggested the association of TTEPs with epithelial-to-mesenchymal transition (EMT), cell-matrix remodeling, and transcriptional dysregulation, while the TTEmiRs (miR-146b-5p and miR-21-5p) were associated with the modulation of the immune response, EMT, migration, cellular proliferation, and stemness. Molecular docking simulations were performed to evaluate binding affinities between TTEPs and antrocinnamomin, antcin, and antrocin, the bioactive compounds from one of the most reputable Taiwan indigenous medicinal plants (Antrodia camphorata). Our results revealed that antcin exhibited higher binding efficacies toward FN1, ETV5, and NRCAM, whereas antrocin demonstrated the least. Among the targets, fibronectin (FN1) demonstrated high ligandability potential for the compounds whereas NRCAM demonstrated the least. Collectively, our results hinted at the potential of antcin for targeting TTEPs. In conclusion, this comprehensive bioinformatics analysis strongly suggested that TTEPs and TTEmiRs could be used as potential diagnostic biomarker signatures and be exploited as potential targets for therapeutics development.https://www.frontiersin.org/articles/10.3389/fcell.2022.923503/fullthyroid carcinoma (THCA)theranostic biomarkersimmune infiltrationepithelial-to-mesenchymal transitiont-cell exclusion
spellingShingle Ming-Lang Shih
Bashir Lawal
Bashir Lawal
Sheng-Yao Cheng
Janet O. Olugbodi
Ahmad O Babalghith
Ching-Liang Ho
Simona Cavalu
Gaber El-Saber Batiha
Sarah Albogami
Saqer S. Alotaibi
Jih-Chin Lee
Alexander T. H. Wu
Alexander T. H. Wu
Alexander T. H. Wu
Alexander T. H. Wu
Large-scale transcriptomic analysis of coding and non-coding pathological biomarkers, associated with the tumor immune microenvironment of thyroid cancer and potential target therapy exploration
Frontiers in Cell and Developmental Biology
thyroid carcinoma (THCA)
theranostic biomarkers
immune infiltration
epithelial-to-mesenchymal transition
t-cell exclusion
title Large-scale transcriptomic analysis of coding and non-coding pathological biomarkers, associated with the tumor immune microenvironment of thyroid cancer and potential target therapy exploration
title_full Large-scale transcriptomic analysis of coding and non-coding pathological biomarkers, associated with the tumor immune microenvironment of thyroid cancer and potential target therapy exploration
title_fullStr Large-scale transcriptomic analysis of coding and non-coding pathological biomarkers, associated with the tumor immune microenvironment of thyroid cancer and potential target therapy exploration
title_full_unstemmed Large-scale transcriptomic analysis of coding and non-coding pathological biomarkers, associated with the tumor immune microenvironment of thyroid cancer and potential target therapy exploration
title_short Large-scale transcriptomic analysis of coding and non-coding pathological biomarkers, associated with the tumor immune microenvironment of thyroid cancer and potential target therapy exploration
title_sort large scale transcriptomic analysis of coding and non coding pathological biomarkers associated with the tumor immune microenvironment of thyroid cancer and potential target therapy exploration
topic thyroid carcinoma (THCA)
theranostic biomarkers
immune infiltration
epithelial-to-mesenchymal transition
t-cell exclusion
url https://www.frontiersin.org/articles/10.3389/fcell.2022.923503/full
work_keys_str_mv AT minglangshih largescaletranscriptomicanalysisofcodingandnoncodingpathologicalbiomarkersassociatedwiththetumorimmunemicroenvironmentofthyroidcancerandpotentialtargettherapyexploration
AT bashirlawal largescaletranscriptomicanalysisofcodingandnoncodingpathologicalbiomarkersassociatedwiththetumorimmunemicroenvironmentofthyroidcancerandpotentialtargettherapyexploration
AT bashirlawal largescaletranscriptomicanalysisofcodingandnoncodingpathologicalbiomarkersassociatedwiththetumorimmunemicroenvironmentofthyroidcancerandpotentialtargettherapyexploration
AT shengyaocheng largescaletranscriptomicanalysisofcodingandnoncodingpathologicalbiomarkersassociatedwiththetumorimmunemicroenvironmentofthyroidcancerandpotentialtargettherapyexploration
AT janetoolugbodi largescaletranscriptomicanalysisofcodingandnoncodingpathologicalbiomarkersassociatedwiththetumorimmunemicroenvironmentofthyroidcancerandpotentialtargettherapyexploration
AT ahmadobabalghith largescaletranscriptomicanalysisofcodingandnoncodingpathologicalbiomarkersassociatedwiththetumorimmunemicroenvironmentofthyroidcancerandpotentialtargettherapyexploration
AT chingliangho largescaletranscriptomicanalysisofcodingandnoncodingpathologicalbiomarkersassociatedwiththetumorimmunemicroenvironmentofthyroidcancerandpotentialtargettherapyexploration
AT simonacavalu largescaletranscriptomicanalysisofcodingandnoncodingpathologicalbiomarkersassociatedwiththetumorimmunemicroenvironmentofthyroidcancerandpotentialtargettherapyexploration
AT gaberelsaberbatiha largescaletranscriptomicanalysisofcodingandnoncodingpathologicalbiomarkersassociatedwiththetumorimmunemicroenvironmentofthyroidcancerandpotentialtargettherapyexploration
AT sarahalbogami largescaletranscriptomicanalysisofcodingandnoncodingpathologicalbiomarkersassociatedwiththetumorimmunemicroenvironmentofthyroidcancerandpotentialtargettherapyexploration
AT saqersalotaibi largescaletranscriptomicanalysisofcodingandnoncodingpathologicalbiomarkersassociatedwiththetumorimmunemicroenvironmentofthyroidcancerandpotentialtargettherapyexploration
AT jihchinlee largescaletranscriptomicanalysisofcodingandnoncodingpathologicalbiomarkersassociatedwiththetumorimmunemicroenvironmentofthyroidcancerandpotentialtargettherapyexploration
AT alexanderthwu largescaletranscriptomicanalysisofcodingandnoncodingpathologicalbiomarkersassociatedwiththetumorimmunemicroenvironmentofthyroidcancerandpotentialtargettherapyexploration
AT alexanderthwu largescaletranscriptomicanalysisofcodingandnoncodingpathologicalbiomarkersassociatedwiththetumorimmunemicroenvironmentofthyroidcancerandpotentialtargettherapyexploration
AT alexanderthwu largescaletranscriptomicanalysisofcodingandnoncodingpathologicalbiomarkersassociatedwiththetumorimmunemicroenvironmentofthyroidcancerandpotentialtargettherapyexploration
AT alexanderthwu largescaletranscriptomicanalysisofcodingandnoncodingpathologicalbiomarkersassociatedwiththetumorimmunemicroenvironmentofthyroidcancerandpotentialtargettherapyexploration